Lifestyle
- Maintain adequate hydration
- Engage in regular moderate exercise
- Monitor protein intake
Creatinine · Serum Creatinine · Crea
Serum creatinine quantifies the concentration of creatinine in the blood, a waste product of muscle metabolism.
Reference ranges may vary based on age, sex, and muscle mass.
Creatinine, also known as Crea, is a waste product formed by the normal breakdown of muscle tissue. It is filtered out of the blood by the kidneys and excreted in urine. Serum creatinine levels are commonly used to assess kidney function, as they reflect the glomerular filtration rate (GFR), albeit indirectly. Researchers have found that while creatinine is a widely used marker, it has limitations due to its variability with muscle mass, diet, and other factors. Clinically, serum creatinine is crucial for diagnosing and monitoring kidney conditions such as acute kidney injury (AKI) and chronic kidney disease (CKD). Elevated creatinine levels often indicate impaired kidney function, while low levels may be less clinically significant but can occur in conditions with reduced muscle mass. For athletes and biohackers, creatinine levels can be influenced by muscle mass and protein intake, making it important to consider these factors when interpreting results. Researchers observed that creatinine measurements can be confounded by factors such as dehydration, high-protein diets, and certain medications. It is important to consider these variables, as well as the time of day and fasting status, when assessing creatinine levels to ensure accurate interpretation.
Klinische Bedeutung
Elevated serum creatinine levels typically indicate reduced kidney function or kidney disease. Low creatinine levels may be observed in individuals with low muscle mass or certain chronic illnesses.
Progressively rising creatinine levels suggest worsening kidney function. Retesting is recommended within 4 weeks if values are outside the optimal range.
Progressively falling creatinine levels may indicate improved kidney function or reduced muscle mass.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant dietary or lifestyle changes, especially if kidney function is impaired.
Creatinine levels may be higher in the morning; consistent timing is recommended.
Testing Frequency
Annually for healthy adults, more frequently if kidney disease is present.
Correlated with
Current research suggests that the reference ranges and optimal targets for serum creatinine in various populations remain debated, particularly in the context of acute kidney injury where small elevations may indicate significant damage. Researchers have not yet established standardized protocols for integrating emerging biomarkers like cystatin C into routine clinical practice for chronic kidney disease assessment. Additionally, clinical questions regarding the identification of "renal angina" and the timing for biomarker assessments in acute kidney injury remain unanswered.
1,828
Total Citations
12
Human/RCT
5.2
Avg. Influence
2025
Latest
This review examined the use of serum creatinine as a biomarker for kidney function. Researchers found that while creatinine is widely used, it has significant limitations that can affect the interpretation of kidney function. The study also discussed alternative biomarkers that may improve kidney function assessment.
Researchers reviewed the impact of exercise on various laboratory parameters, including serum creatinine. They found that creatinine levels in athletes should be interpreted with consideration of body mass index and training phase, suggesting that cystatin C may be a better alternative for assessing renal function in this population.
This paper assessed the use of serum cystatin C as a biomarker for chronic kidney disease (CKD). Researchers found that cystatin C can be a more accurate early indicator of CKD compared to serum creatinine, particularly in patients where creatinine is inadequate. The study highlights the importance of transitioning to standardized measurement methods for better patient care.
This article explored the concept of 'renal angina' in relation to acute kidney injury (AKI). Researchers found that small increases in serum creatinine may indicate serious kidney damage, suggesting that creatinine is a late marker for AKI. The study emphasizes the need for earlier detection methods to improve patient outcomes.
This article explained how glomerular filtration rate (GFR) can be estimated using serum creatinine and cystatin C. Researchers noted that small increases in these biomarkers can indicate significant decreases in GFR, which is crucial for diagnosing chronic kidney disease.
This review examined the limitations of serum creatinine (SCr) as a biomarker for renal function and muscle mass, particularly in the context of muscle wasting in critically ill patients. Researchers found that factors like chronic inflammation and malnutrition affect SCr levels, suggesting that alternative measures, such as the sarcopenia index, may be more reliable for assessing muscle mass.
This study reviewed the importance of early detection of acute kidney injury (AKI) using biomarkers. Researchers found that new biomarkers could improve the diagnosis and risk prediction for AKI, and highlighted the need for integrating glomerular function and tubular injury markers in clinical practice.
This research identified predictors of end-stage renal disease (ESRD) in Okinawa, Japan. Researchers found that high serum creatinine levels were strong predictors of ESRD, alongside factors like proteinuria and hypertension. The study suggests that monitoring these indicators is essential for early intervention.
This article discussed the significance of serum creatinine and urea nitrogen levels in assessing renal function. Researchers found that serum creatinine is a more reliable indicator than urea nitrogen, and emphasized the importance of interpreting these levels together for accurate kidney function assessment.
This article discussed the implementation of estimated glomerular filtration rate (eGFR) reporting in clinical laboratories. Researchers found that standardized creatinine methods have improved the accuracy of eGFR calculations, which are essential for identifying early-stage chronic kidney disease.
Research publications about Kreatinin over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer